Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 6Other hematologic neoplasm 3Myeloid 2Breast 2Plasma cell 1Gynecologic 1Classical hematology 1

Conditions

Neoplasms 5Splenomegaly 2Leukemia 2Fatigue 2Anemia, Sickle Cell 2Anemia 2Weight Loss 1Venous Thromboembolism 1Thrombocytopenia 1Smoking Cessation 1Smoking 1Primary Myelofibrosis 1Plexosarcoma 1Ovarian Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphocytosis 1Lymphadenopathy 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Gastrointestinal Stromal Tumors 1Fever 1Febrile Neutropenia 1Fanconi Anemia, Complementation Group D1 1Cancer-related Venous Thromboembolism 1Breast Neoplasms 1Anemia, Iron-Deficiency 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 34fludarabine phosphate 32Mycophenolic Acid 27Whole-Body Irradiation 21Peripheral Blood Stem Cell Transplantation 21Tacrolimus 19Melphalan 18Cyclosporine 17fludarabine 16Busulfan 16Antilymphocyte Serum 16Filgrastim 12Cord Blood Stem Cell Transplantation 9Methotrexate 8Radiotherapy 7Methylprednisolone 6Granulocyte Colony-Stimulating Factor 6Sirolimus 5Rituximab 5Epoetin Alfa 5Etoposide 4Cytarabine 4Alemtuzumab 4thymoglobulin 3Therapeutics 3Stem Cell Transplantation 3Darbepoetin alfa 3Clofarabine 3CT-P10 3Bortezomib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hodgkin Disease × Surveys and Questionnaires × Classical hematology × Clear all
NCT00510315 2020-12-07

Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant

Memorial Sloan Kettering Cancer Center

Completed
11 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Aplastic, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡